Idelalisib
CAS: 870281-82-6
Molecular Formula: C22H18FN7O
Molecular weight:415.4230232
Density:1.47g/cm3
Use :Idelalisib is a second-line drug for patients whose chronic lymphocytic leukemia (CLL) has relapsed. Used in combination with rituximab,idelalisib is to be used in patients for whom rituximab alone would be considered appropriate therapy due to other existing medical conditions.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: